Position Nº 01PHARMA / MENAStatus: Settled
Roche Diabetes Care
Launched an AI-enabled CGM across four Gulf markets under MOHAP and SFDA pharma rules.
Realized returns
- Kuwait, Qatar, KSA and UAE launched under MOHAP + SFDA
- Aided brand awareness lift in target diabetes audience (Kantar)
- HCP-safe inventory pre-cleared via ChannelFactory
The order
MENA pharma advertising sits inside a separate rulebook from e-commerce: UAE MOHAP and Saudi SFDA require pre-approval, prohibit prescription DTC claims, and treat HCP and patient audiences as legally distinct. Most regional agencies don't know these rules until campaigns get paused. Roche needed a four-market launch (Kuwait, Qatar, KSA, then UAE) where every asset, audience and placement was compliant from day one and brand metrics, not last-click ROAS, were the measurement layer.
How it was won
- 01
Built a four-market media plan with budget weighted by population, GDP-per-capita and IDF-published diabetes prevalence data
- 02
Pre-cleared every YouTube channel via a ChannelFactory contextual whitelist tuned for HCP-safe and patient-safe inventory at the placement level
- 03
Locked compliance gates with Meta Business Portfolio and Google policy teams pre-flight, not post-rejection
- 04
Designed a brand-lift measurement plan (Kantar and Meta Brand Lift) reading aided awareness, message recall and intent as the right pharma KPIs
Worked with
- Meta
- Google Ads
- YouTube
- ChannelFactory
- Pharma Compliance (MOHAP/SFDA)
- Brand Lift Study
- Multi-market Launch
Adjacent positions
Want returns like these on your book?
Two retainer seats open for the Q3 2026 series.